enVVeno Medical Corp (NVNO)
enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
enVVeno Medical Corporation
No short interest data available.
Nasdaq bars a compliance period at 1:250
- 1:35Reverse splitJan 20, 202635 shares → 1
- 1:25Reverse splitNov 30, 202025 shares → 1
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $31K | $187K | $422K | $786K | $0 | $237K |
| YoY Growth | - | - | - | - | - | - | -83.3% | -55.8% | -46.3% | - | - | - |
| Cost of Revenue | $0 | $528K | $546K | $525K | $453K | $384K | $0 | $0 | $559K | $961K | $125K | $266K |
| Gross Profit | $0 | -$528K | -$546K | -$525K | -$453K | -$384K | $31K | $187K | -$137K | -$176K | -$125K | -$30K |
| Gross Margin | - | - | - | - | - | - | 100.0% | 100.0% | -32.4% | -22.3% | - | -12.7% |
| Research and Development | $9.98M | $12.25M | $13.58M | $9.91M | $5.73M | $4.25M | $2.21M | $1.24M | $650K | $0 | $0 | $0 |
| Selling, General, and Administrative | $10.92M | $11.05M | $11.11M | $14.49M | $10.71M | $4.5M | $4.51M | $6.35M | $5.32M | $4.48M | $1.16M | $923K |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $985K | $453K | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $20.9M | $23.3M | $24.69M | $24.41M | $16.44M | $8.75M | $7.71M | $8.04M | $5.97M | $4.48M | $1.16M | $923K |
| Operating Income (EBIT) | -$20.9M | -$23.83M | -$25.24M | -$24.93M | -$16.89M | -$9.14M | -$7.68M | -$7.85M | -$6.1M | -$4.66M | -$1.29M | -$953K |
| Operating Margin | - | - | - | - | - | - | -24566.5% | -4210.5% | -1445.9% | -592.8% | - | -402.8% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | -$4K | $933 | $6.86M | $1.92M | $58K | $89K | $65K |
| Interest Income | $692K | $389K | $180K | $161K | $19K | $0 | $51K | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | $1.43M | $2.01M | $1.72M | $263K | $365K | -$360 | $50K | -$5.19M | -$1.69M | -$929K | -$88K | -$65K |
| Income Before Tax (EBT) | -$19.47M | -$21.82M | -$23.52M | -$24.67M | -$16.53M | -$9.14M | -$7.63M | -$13.04M | -$7.79M | -$5.59M | -$1.38M | -$1.02M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$19.47M | -$21.82M | -$23.52M | -$24.67M | -$16.53M | -$9.14M | -$7.63M | -$13.04M | -$7.79M | -$5.89M | -$1.6M | -$1.4M |
| Net Income Margin | - | - | - | - | - | - | -24406.7% | -6991.5% | -1845.8% | -749.0% | - | -591.1% |
| Supplementary Data | ||||||||||||
| EPS | -33.06 | -1555.75 | -2339.75 | -2695.00 | -2327.50 | -9236.50 | -14822.50 | -53495.75 | -26068.00 | -10412.50 | -4483.50 | -5194.00 |
| Diluted EPS | -33.06 | -1555.75 | -2339.75 | -2695.00 | -2327.50 | -9236.50 | -14822.50 | -53495.75 | -26068.00 | -10412.50 | -4483.50 | -5194.00 |
| Weighted Average OS | 589,000 | 13,993 | 10,042 | 9,167 | 7,086 | 1,054 | 515 | 306 | 316 | 358 | 358 | 196 |
| EBITDA | -$18.98M | -$21.29M | -$22.97M | -$24.14M | -$16.07M | -$8.75M | -$7.23M | -$6.05M | -$5.73M | -$5.38M | -$1.16M | -$819K |
| EBITDA Margin | - | - | - | - | - | - | -23134.1% | -3242.2% | -1358.1% | -684.5% | - | -346.1% |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Assets | ||||||||||||
| Current Assets | ||||||||||||
| Cash and Cash Equivalents | $3.06M | $1.75M | $3.62M | $4.55M | $54.73M | $9.33M | $1.31M | $2.74M | $78K | $57K | $1.59M | $58K |
| Short-Term Investments | $25.15M | $41.4M | $42.79M | $34.49M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $28.21M | $43.15M | $46.41M | $39.04M | $54.73M | $9.33M | $1.31M | $2.74M | $78K | $57K | $1.59M | $58K |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $32K | $35K | $200K | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $91K | $0 | $0 |
| Other Current Assets | $614K | $581K | $511K | $392K | $312K | $234K | $117K | $64K | $58K | $0 | $184K | $392K |
| Total Current Assets | $28.83M | $43.73M | $46.92M | $39.44M | $55.04M | $9.57M | $1.42M | $2.84M | $170K | $393K | $1.78M | $485K |
| Long-Term Assets | ||||||||||||
| Property, Plant & Equipment Net | $705K | $1.19M | $1.68M | $2.19M | $2.6M | $939K | $1.17M | $26K | $24K | $29K | $65K | $110K |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $666K | $1.11M | $1.23M | $899K | $977K |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $810K | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $31K | $31K | $31K | $31K | $54K | $30K | $30K | $30K | $911K | $128K | $126K | $26K |
| Total Long-Term Assets | $736K | $1.22M | $1.71M | $2.23M | $2.66M | $969K | $2.01M | $722K | $2.04M | $1.39M | $1.09M | $1.11M |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $29.56M | $44.95M | $48.63M | $41.66M | $57.7M | $10.54M | $3.43M | $3.56M | $2.21M | $1.78M | $2.87M | $1.6M |
| Liabilities | ||||||||||||
| Current Liabilities | ||||||||||||
| Accounts Payable | $358K | $1.01M | $427K | $648K | $560K | $1.39M | $1.22M | $1.08M | $1.45M | $542K | $618K | $702K |
| Short-Term Debt | $0 | $364K | $0 | $0 | $0 | $313K | $0 | $0 | $2.62M | $633K | $1.83M | $1.07M |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $26K | $30K | $27K | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $33K | $33K | $33K | $103K | $0 | $0 | $33K |
| Other Current Liabilities | $929K | $121K | $606K | $450K | $585K | $499K | $152K | $311K | $3.64M | $857K | $2.16M | $1.66M |
| Total Current Liabilities | $2.12M | $2.1M | $1.37M | $1.53M | $1.58M | $3.19M | $1.88M | $1.52M | $8.17M | $2.07M | $4.66M | $3.61M |
| Long-Term Liabilities | ||||||||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $33K | $103K | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.08M | $551K | $74K | $0 |
| Total Long-Term Liabilities | $310K | $700K | $1.06M | $1.4M | $1.71M | $254K | $568K | $33K | $3.18M | $551K | $74K | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $2.43M | $2.79M | $2.44M | $2.93M | $3.29M | $3.44M | $2.44M | $1.52M | $8.17M | $2.07M | $4.66M | $3.61M |
| Stockholders' Equity | ||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $5.17M | $3.94M | $1.8M | $0 |
| Common Stock | $0 | $0 | $0 | $0 | $95 | $25 | $179 | $117 | $61 | $122 | $120 | $120 |
| Retained Earnings | -$171.33M | -$151.85M | -$130.04M | -$106.52M | -$81.85M | -$65.32M | -$56.19M | -$48.56M | -$35.52M | -$27.73M | -$24.34M | -$22.74M |
| Comprehensive Income & Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$5.17M | -$3.94M | $0 | $0 |
| Other Stockholders' Equity | $198.46M | $194.01M | $176.24M | $145.25M | $136.26M | $72.42M | $57.18M | $50.6M | $24.39M | $23.51M | $22.56M | $20.73M |
| Total Equity | $27.13M | $42.16M | $46.2M | $38.73M | $54.4M | $7.1M | $990K | $2.04M | -$11.13M | -$4.22M | -$1.78M | -$2.01M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $29.56M | $44.95M | $48.63M | $41.66M | $57.7M | $10.54M | $3.43M | $3.56M | -$2.96M | -$2.15M | $2.87M | $1.6M |
| Supplementary Data | ||||||||||||
| Total Debt | $700K | $1.06M | $1.4M | $1.72M | $2.01M | $881K | $857K | $0 | $2.62M | $633K | $1.83M | $1.07M |
| Net Debt | -$2.37M | -$690K | -$2.22M | -$2.84M | -$52.72M | -$8.45M | -$451K | -$2.74M | $2.54M | $576K | $246K | $1.01M |
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 |
| Operating Activities | ||||||||||||
| Net Income | -$19.47M | -$21.82M | -$23.52M | -$24.67M | -$16.53M | -$9.14M | -$7.63M | -$13.04M | -$7.79M | -$3.39M | -$1.6M | -$1K |
| Depreciation & Amortization | $489K | $528K | $546K | $525K | $453K | $384K | $397K | $133K | $139K | $151K | $125K | $134K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $3.42M | $4.14M | $5.2M | $8.99M | $6M | $881K | $942K | $1.92M | $878K | $1.51M | $0 | $0 |
| Changes in Working Capital: | ||||||||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $32K | $3K | -$12K | -$24K | $25K | -$6 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $91K | -$213K | $172K | -$152 |
| Accounts Payable | $0 | $0 | -$221K | $88K | -$833K | $169K | $144K | -$294K | $545K | -$76K | -$84K | $0 |
| Other Working Capital | -$396K | $290K | -$395K | -$508K | -$313K | $497K | -$109K | -$287K | $468K | $250K | -$654K | $159 |
| Total Working Capital Change | -$396K | $290K | -$616K | -$420K | -$1.15M | $666K | $67K | -$578K | $1.09M | -$63K | -$541K | $0 |
| Other Non-Cash Items | $391K | $22K | -$468K | -$49K | -$626K | -$473K | $324K | $5.21M | $1.48M | -$1.63M | -$177 | -$133K |
| Net Cash from Operating | -$15.57M | -$16.84M | -$18.86M | -$15.62M | -$11.85M | -$7.68M | -$5.9M | -$6.36M | -$4.2M | -$3.42M | -$2.02M | $122 |
| Investing Activities | ||||||||||||
| Capital Expenditures | -$5K | -$37K | -$33K | -$115K | -$368K | -$180K | -$364K | -$12K | -$11K | -$3K | -$3K | -$31 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | -$46.02M | -$55.57M | -$56.52M | -$48.13M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $61.88M | $56.94M | $48.69M | $13.69M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $176K | -$369K | -$75K | $0 |
| Net Cash from Investing | $15.86M | $1.33M | -$7.87M | -$34.55M | -$368K | -$180K | -$364K | -$12K | $165K | -$373K | -$78K | -$31 |
| Financing Activities | ||||||||||||
| Debt Repaid | - | - | - | - | - | -$313K | - | -$723K | -$275K | - | - | - |
| Common Stock Issuance | $1.02M | $13.64M | $25.79M | $0 | $57.61M | $10.42M | $5.64M | $7.66M | $0 | $0 | $0 | $0 |
| Common Stock Repurchases | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | $0 | $0 | $0 | $0 | $0 | $2.99M | $0 | -$707K | -$210K | -$589K | $746K | $60K |
| Net Cash from Financing | $1.02M | $13.64M | $25.79M | $0 | $57.61M | $15.07M | $5.64M | $9.03M | $4.06M | $2.26M | $3.62M | -$60 |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $1.31M | -$1.87M | -$935K | -$50.17M | $45.39M | $7.22M | -$623K | $2.66M | $21K | -$1.53M | $1.53M | $31 |
| Supplementary Data | ||||||||||||
| Operating Cash Flow | -$15.57M | -$16.84M | -$18.86M | -$15.62M | -$11.85M | -$7.68M | -$5.9M | -$6.36M | -$4.2M | -$3.42M | -$2.02M | $122 |
| Capital Expenditure | -$5K | -$37K | -$33K | -$115K | -$368K | -$180K | -$364K | -$12K | -$11K | -$374K | -$3K | -$31 |
| Free Cash Flow | -$15.57M | -$16.88M | -$18.89M | -$15.73M | -$12.22M | -$7.86M | -$6.26M | -$6.37M | -$4.21M | -$3.79M | -$2.02M | $91 |
| Cash at Beginning | $1.75M | $3.62M | $4.55M | $54.73M | $9.34M | $2.12M | $2.74M | $78K | $57K | $1.59M | $58K | $27 |
| Cash at End | $3.06M | $1.75M | $3.62M | $4.55M | $54.73M | $9.33M | $2.12M | $2.74M | $78K | $57K | $1.59M | $58 |